SCHEMBL24361672

SCHEMBL24361672

c1ccc(-c2ccc(N(c3ccc(-c4ccc(-c5cc6ccccc6c6ccccc56)cc4)cc3)c3ccc4c(c3)oc3cc5ccccc5cc34)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR84 Q9NQS5 3/20 0.37
▸ CYP11B1 P15538 1/20 0.36
▸ KDM4E B2RXH2 4/20 0.35
▸ MEN1 O00255 4/20 0.35
▸ KMT2A Q03164 4/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ MAPT P10636 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ MPI P34949 1/20 0.35
▸ MAOB P27338 3/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ AKR1B1 P15121 2/20 0.33
▸ CA12 O43570 1/20 0.33
▸ ALDH2 P05091 1/20 0.33
▸ MAOA P21397 1/20 0.33
▸ HSD17B3 P37058 1/20 0.33
▸ SORD Q00796 1/20 0.33
▸ CA9 Q16790 1/20 0.33
▸ ALOX5 P09917 1/20 0.33
▸ RECQL P46063 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24361596 1.00 GPR84 (0.37) GPR84CYP11B1KDM4EMEN1KMT2A
SCHEMBL24361319 0.96 GPR84 (0.36) GPR84CYP11B1KDM4EMEN1KMT2A
SCHEMBL24361674 0.95 GPR84 (0.34) GPR84CYP11B1KDM4EMEN1KMT2A
SCHEMBL26020792 0.95 GPR84 (0.34) GPR84CYP11B1KDM4EMEN1KMT2A
SCHEMBL24361317 0.95 GPR84 (0.34) GPR84CYP11B1KDM4EMEN1KMT2A
SCHEMBL24361666 0.94 GPR84 (0.36) GPR84CYP11B1KDM4EMEN1KMT2A
SCHEMBL26020516 0.94 GPR84 (0.35) GPR84CYP11B1KDM4EMEN1KMT2A
SCHEMBL26020738 0.94 CYP11B1 (0.34) GPR84CYP11B1KDM4EMEN1KMT2A
SCHEMBL24362111 0.94 CYP11B1 (0.34) GPR84CYP11B1KDM4EMEN1KMT2A
SCHEMBL26020737 0.93 GPR84 (0.33) GPR84CYP11B1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242498-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2023-08-03 — — US disclosed
US-20230242498-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2023-08-03 — — US disclosed
WO-2022086171-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2022-04-28 — — WO disclosed
WO-2022086168-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2022-04-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242498-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CRY2, NR1D1 GPR84 1568/4885CYP11B1 469/4885KDM4E 3533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback